Hong Kong
· Delayed Price · Currency is HKD Kintor Pharmaceutical Statistics
Total Valuation
HKG:9939 has a market cap or net worth of HKD 506.57 million. The enterprise value is 489.88 million.
| Market Cap | 506.57M |
| Enterprise Value | 489.88M |
Important Dates
The next estimated earnings date is Monday, May 26, 2025.
| Earnings Date | May 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9939 has 432.97 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 432.97M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 11.29% |
| Owned by Institutions (%) | 4.40% |
| Float | 359.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 95.20 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.96 |
| EV / Sales | 92.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.03 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.13 |
Financial Efficiency
Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -16.42%.
| Return on Equity (ROE) | -41.29% |
| Return on Assets (ROA) | -13.51% |
| Return on Invested Capital (ROIC) | -16.42% |
| Return on Capital Employed (ROCE) | -42.94% |
| Revenue Per Employee | 31,672 |
| Profits Per Employee | -983,675 |
| Employee Count | 168 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.04% in the last 52 weeks. The beta is -0.10, so HKG:9939's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +26.04% |
| 50-Day Moving Average | 1.19 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 50.87 |
| Average Volume (20 Days) | 2,667,475 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9939 had revenue of HKD 5.32 million and -165.26 million in losses. Loss per share was -0.38.
| Revenue | 5.32M |
| Gross Profit | -5.03M |
| Operating Income | -159.21M |
| Pretax Income | -165.24M |
| Net Income | -165.26M |
| EBITDA | -145.07M |
| EBIT | -159.21M |
| Loss Per Share | -0.38 |
Balance Sheet
The company has 158.23 million in cash and 141.54 million in debt, giving a net cash position of 16.69 million or 0.04 per share.
| Cash & Cash Equivalents | 158.23M |
| Total Debt | 141.54M |
| Net Cash | 16.69M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 312.95M |
| Book Value Per Share | 0.73 |
| Working Capital | 5.38M |
Cash Flow
| Operating Cash Flow | -211.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -94.60% |
| Operating Margin | -2,992.26% |
| Pretax Margin | -3,105.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:9939 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | -0.39% |
| Earnings Yield | -32.62% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |